Best Pharmaceutical Stocks To Watch Today - May 1st

Key Points

• MarketBeat's screener identifies Eli Lilly (LLY), Novo Nordisk (NVO), and Abbott Laboratories (ABT) as the three pharmaceutical stocks to watch today based on the highest dollar trading volume over the past several days.
• Pharmaceutical stocks carry elevated volatility and risk because their prices often move sharply on clinical trial results, regulatory approvals or setbacks, patent expirations, and drug‑pricing policy changes.
• Eli Lilly is highlighted for widening its lead in the GLP‑1 market after a "double‑beat" performance, and a potential new pill could make that advantage more permanent.

Eli Lilly and Company, Novo Nordisk A/S, and Abbott Laboratories are the three Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded companies whose primary business is researching, developing, manufacturing, and selling prescription drugs, vaccines, and related therapies. For investors, they carry high R&D costs and regulatory sensitivity—prices often move sharply on clinical trial results, regulatory approvals or setbacks, patent expirations, and changes in drug-pricing policy, offering the potential for sizable gains but also elevated risk and volatility. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Read Our Latest Research Report on LLY

Novo Nordisk A/S (NVO)

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.

Read Our Latest Research Report on NVO

Abbott Laboratories (ABT)

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon.

Read Our Latest Research Report on ABT

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.